Tumaini trial to test 2 Bundibugyo Ebola vaccines in DRC
The planned trials would expand a response strained by record DRC deaths, rising weekly cases and the absence of approved Bundibugyo vaccines.

WHO said at a Geneva press conference on Tuesday that two Bundibugyo-specific Ebola vaccine candidates are expected to enter clinical testing in eastern DRC as early as next week.
The announcement comes as the Democratic Republic of Congo faces 5,568 confirmed deaths out of 11,376 cases, according to WHO figures cited by RFI, in the country’s worst Ebola outbreak.
“We expect two candidate vaccines developed specifically for Bundibugyo virus to begin testing as early as next week,” WHO Director-General Tedros Adhanom Ghebreyesus said at the press conference.
The candidates will be tested under the Tumaini trial, which is assessing whether vaccines can safely protect against the Bundibugyo species of Ebola and produce an immune response. The trial uses ring vaccination, a containment strategy that immunises people considered at high risk because of contact with cases.
Ervebo, an approved vaccine for the more common Zaire strain of Ebola, began the Tumaini trial on Oct. 23 at Phase 3, the large-scale stage used to measure protection. That arm is testing whether Ervebo offers any defence against Bundibugyo, for which there are currently no approved vaccines or treatments.
The two Bundibugyo-specific candidates have each completed Phase 1 clinical trials, the early stage focused on initial safety. One is a ChAdOx1 adenoviral-vector vaccine developed by the University of Oxford, and the other is Moderna’s mRNA-1469, which uses messenger RNA technology.
Meg Doherty, head of WHO’s science for health department, said Phase 2 trials are scheduled to start on Nov. 26 or Nov. 27 in Bunia, the capital of Ituri province and the outbreak’s epicentre. Phase 2 studies typically examine safety and immune response in a larger group before a vaccine can move to full-scale Phase 3 testing.
Doherty said more than 140 people had joined the Tumaini trial, with thousands of contacts ultimately expected to participate. The trial is also expected to expand beyond its current single site in Bunia.
The outbreak was declared in May and triggered an international public health emergency. RFI reported that case numbers and deaths were still increasing at what it described as a record pace six months into the epidemic, while resource shortages, instability and weak coordination have hindered containment.
Tedros said 400 to 500 new cases were still being reported each week, and that two-thirds of confirmed deaths were occurring outside Ebola treatment centres. “Children are paying a terrible price. They account for more than a quarter of confirmed cases and one third of deaths,” he said.
Ebola spreads through contact with bodily fluids and causes haemorrhagic fever. It has killed more than 15,000 people in Africa over the past 50 years, according to RFI.
The next test for the response is whether the two candidates begin Phase 2 testing in Bunia on Nov. 26 or Nov. 27 and whether their safety and immune-response data clear review for a possible Phase 3 trial.
Source: News report, Radio France Internationale via AllAfrica, published Nov. 19, 2026.
More stories
- GSK wins FDA approval for Nelkarmi after 49% response rate
- Europe faces 35,000 drug-resistance deaths a year
- U.S. faces loss of measles elimination status after 5,412 cases
- Congo Ebola outbreak spreads to 8 provinces
- Daily iron tablets cut anaemia risk in children across 114 studies
- Americans face health concerns from 6-8 daily sitting hours
Latest news
- 30-year mortgage APR falls 8bp to 7.19%
- Vehicle service contracts can cost several thousand dollars a year
- South Africa recycles 301,000 tonnes of plastic waste
- Iran caps subsidized bread at 8kg a month in three provinces
- Jeff Buckley track tops 500,000 TikTok uses this year
- Iraq hits suspected ISIS sites with 2 strikes after US exit
- Singapore charges 2 men over 19 deregistered vehicles
- Kenya construction regulators face scrutiny after 84 collapses

